Texas Yale Capital Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
1,924
-10
| -0.5% | -$5.25K | 0.03% | 259 |
|
|
2025
Q1 | $1.23M | Hold |
1,934
| – | – | 0.05% | 239 |
|
|
2024
Q4 | $1.38M | Hold |
1,934
| – | – | 0.06% | 220 |
|
|
2024
Q3 | $2.03M | Hold |
1,934
| – | – | 0.09% | 190 |
|
|
2024
Q2 | $2.03M | Hold |
1,934
| – | – | 0.1% | 170 |
|
|
2024
Q1 | $1.86M | Hold |
1,934
| – | – | 0.08% | 182 |
|
|
2023
Q4 | $1.7M | Buy |
1,934
+10
| +0.5% | +$8.78K | 0.08% | 188 |
|
|
2023
Q3 | $1.58M | Hold |
1,924
| – | – | 0.07% | 184 |
|
|
2023
Q2 | $1.38M | Hold |
1,924
| – | – | 0.07% | 201 |
|
|
2023
Q1 | $1.58M | Hold |
1,924
| – | – | 0.08% | 191 |
|
|
2022
Q4 | $1.39M | Hold |
1,924
| – | – | 0.08% | 201 |
|
|
2022
Q3 | $1.33M | Buy |
+1,924
| New | +$1.33M | 0.08% | 198 |
|